Concord Biotech clears Kenya, Uganda regulatory inspection
The inspection was conducted from June 18 to June 24, 2026
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Concord Biotech
Concord Biotech gets SEBI nod for IPO
The issue with a face value of Re 1 per equity share is a complete Offer For Sale (OFS) aggregating to 20,925,652 equity shares by…
Concord Biotech files DRHP for IPO
The issue with a face value of Re 1 per equity share is a complete Offer For Sale (OFS) aggregating to 20,925,652 equity shares by…
Lupin launches Tacrolimus Capsules USP
They are indicated for the prophylaxis of organ rejection in combination with other immunosuppressants
Lupin, Concord, receive US FDA approval for Mycophenolate Mofetil tablets USP
They are indicated for the prophylaxis of organ rejection in recipients of allogeneic kidney, heart or liver transplants, in…
PLI scheme guidelines evoke mix reviews from industry
Some laud the measures taken by the government while others list aspects that should have been considered under the scheme's…
Govt may allow 30 per cent import of chemicals/intermediates in PLI scheme
In the next phase of the PLI scheme, the government has plans to incentivise excipient manufacturers
Lupin launches Mycophenolic Acid Delayed-Release Tablets USP
Mycophenolic Acid Delayed-Release Tablets USP, 180 mg and 360 mg, is the generic equivalent of Myfortic Delayed-Release Tablets,…